PTCT PTC Therapeutics Forecast, Technical & Fundamental Analysis
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders... Show more
PTCT is expected to report earnings to fall 993.67% to 26 cents per share on July 30
Q2'26
Est.
$0.27
Q1'26
Beat
by $0.43
Q4'25
Missed
by $1.41
Q3'25
Beat
by $1.32
Q2'25
Beat
by $0.23
The last earnings report on May 07 showed earnings per share of -2 cents, beating the estimate of -46 cents. With 560.24K shares outstanding, the current market capitalization sits at 6.12B.
A.I.dvisor indicates that over the last year, PTCT has been loosely correlated with INCY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PTCT jumps, then INCY could also see price increases.
The Moving Average Convergence Divergence (MACD) for PTCT turned positive on June 09, 2026. Looking at past instances where PTCT's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where PTCT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 05, 2026. You may want to consider a long position or call options on PTCT as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
PTCT moved above its 50-day moving average on June 04, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for PTCT crossed bullishly above the 50-day moving average on May 12, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PTCT advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The 10-day RSI Indicator for PTCT moved out of overbought territory on May 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PTCT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
PTCT broke above its upper Bollinger Band on May 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PTCT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (19.567). P/E Ratio (7.508) is within average values for comparable stocks, (35.932). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.687). PTCT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.039). P/S Ratio (7.788) is also within normal values, averaging (355.865).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
